Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
CDKN2A homozygous deletion is a strong adverse prognosis ... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas
0
Authors
Romain Appay
16 more
Romain Appay
•
Caroline Dehais
14 more
•
Dominique Figarella‐Branger
Published
July 11, 2019
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Neuro-Oncology
Topics
Biology
Ecology
Medicine
Biochemistry
Cancer Oncology
Show all topics
DOI
10.1093/neuonc/noz124
